Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034069 (
pulmonary fibrosis
)
7,050
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reactive oxygen species (ROS) regulate cell fate, although signaling molecules that regulate ROS hormesis remain unclear. Here we show that
transmembrane 4 L six family member 5
(
TM4SF5
) in lung epithelial cells induced the alternatively spliced CD44v8-10 variant via an inverse ZEB2/epithelial splicing regulatory proteins (ESRPs) linkage.
TM4SF5
formed complexes with the cystine/glutamate antiporter system via
TM4SF5
- and CD44v8-10-dependent CD98hc plasma-membrane enrichment. Dynamic
TM4SF5
binding to CD98hc required CD44v8-10 under ROS-generating inflammatory conditions.
TM4SF5
and CD44v8-10 upregulated cystine/glutamate antiporter activity and intracellular glutathione levels, leading to ROS modulation for cell survival. Tm4sf5-null mice exhibited attenuated bleomycin-induced
pulmonary fibrosis
with lower CD44v8-10 and ESRPs levels than wild-type mice. Primary mouse alveolar epithelial cells (AECs) revealed type II AECs (AECII), but not type I, to adapt the
TM4SF5
-mediated characteristics, suggesting
TM4SF5
-mediated AECII survival following AECI injury during idiopathic pulmonary fibrosis (IPF). Thus, the
TM4SF5
-mediated CD44v8-10 splice variant could be targeted against IPF.
...
PMID:TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis. 3150 17